We studied 3 Bpnt2 mutations, which happen to be in close proximity to the active site/metal-binding domain (one that ablates catalytic activity, two that are known to cause chondrodysplasia in humans (8)). This evidence concerns the gene BPNT2 and chondrodysplasia.